Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Interactive Brokers Group, Inc. (IBKR): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?

Page 1 of 2

Is Interactive Brokers Group, Inc. (NASDAQ:IBKR) a good investment?

At the moment, there are tons of gauges shareholders can use to monitor their holdings. A couple of the best are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite investment managers can outclass the S&P 500 by a significant margin (see just how much).

Just as key, positive insider trading sentiment is another way to analyze the marketplace. Just as you’d expect, there are lots of reasons for an insider to get rid of shares of his or her company, but only one, very obvious reason why they would buy. Many empirical studies have demonstrated the impressive potential of this strategy if “monkeys” know what to do (learn more here).

Thus, let’s examine the recent info about Interactive Brokers Group, Inc. (NASDAQ:IBKR).

What does the smart money think about Interactive Brokers Group, Inc. (NASDAQ:IBKR)?

Heading into Q3, a total of 13 of the hedge funds we track were long in this stock, a change of 0% from one quarter earlier. With hedge funds’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were boosting their holdings significantly.

Interactive Brokers Group, Inc. (NASDAQ:IBKR)When using filings from the hedgies we track, Quincy Lee’s Ancient Art (Teton Capital) had the largest position in Interactive Brokers Group, Inc. (NASDAQ:IBKR), worth close to $43.1 million, comprising 11.8% of its total 13F portfolio. The second largest stake is held by Citadel Investment Group, managed by Ken Griffin, which held a $26.9 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Other hedgies that are bullish include David Dreman’s Dreman Value Management, Chuck Royce’s Royce & Associates and Jim Simons’s Renaissance Technologies.

As Interactive Brokers Group, Inc. (NASDAQ:IBKR) has witnessed a fall in interest from the top-tier hedge fund industry, we can see that there lies a certain “tier” of funds who sold off their entire stakes in Q1. At the top of the heap, Peter Rathjens Bruce Clarke and John Campbell’s Arrowstreet Capital said goodbye to the largest stake of all the hedgies we monitor, totaling close to $2 million in stock. Paul Tudor Jones’s fund, Tudor Investment Corp, also dropped its stock, about $0.3 million worth. These moves are interesting, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

What have insiders been doing with Interactive Brokers Group, Inc. (NASDAQ:IBKR)?

Bullish insider trading is best served when the primary stock in question has seen transactions within the past six months. Over the last half-year time period, Interactive Brokers Group, Inc. (NASDAQ:IBKR) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also take a look at the relationship between both of these indicators in other stocks similar to Interactive Brokers Group, Inc. (NASDAQ:IBKR). These stocks are GFI Group Inc. (NYSE:GFIG), Medley Capital Corp (NYSE:MCC), FXCM Inc (NYSE:FXCM), Piper Jaffray Companies (NYSE:PJC), and BGC Partners, Inc. (NASDAQ:BGCP). All of these stocks are in the investment brokerage – national industry and their market caps resemble IBKR’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!